Learning Objectives

1. Discuss Neoantigen Mechanisms: Gain a comprehensive understanding of the mechanisms by which neoantigens are generated and recognized by the immune system, including the processes of antigen presentation and immune activation.

2. Evaluate Current Strategies: Gain insights into cutting-edge approaches for identifying and targeting neoantigens in cancer immunotherapy, including advancements in vaccine development and adoptive cell therapies. Discover the emerging potential of circular RNA as a novel platform for cancer vaccines, emphasizing its enhanced stability and efficacy in presenting neoantigens to the immune system for more robust therapeutic responses.

3. Explore Manufacturing and Quality Control: Understand the critical manufacturing strategies and quality control processes necessary for the successful development and production of neoantigen-based therapies, ensuring consistency, safety, and efficacy.